Primitive Neuroectodermal Tumor.
Rios CI, De Jesus O.
2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Genetically engineered cerebral organoids model brain tumor formation.
Bian S, Repic M, Guo Z, Kavirayani A, Burkard T, Bagley JA, Krauditsch C, Knoblich JA.
Nat Methods. 2018 Aug;15(8):631-639. doi: 10.1038/s41592-018-0070-7. Epub 2018 Jul 23.
Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy.
Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT.
Front Endocrinol (Lausanne). 2021 Sep 1;12:728088. doi: 10.3389/fendo.2021.728088. eCollection 2021.
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Keck MK, Sill M, Wittmann A, Joshi P, Stichel D, Beck P, Okonechnikow K, Sievers P, Wefers AK, Roncaroli F, Avula S, McCabe MG, Hayden JT, Wesseling P, Øra I, Nistér M, Kranendonk MEG, Tops BBJ, Zapotocky M, Zamecnik J, Vasiljevic A, Fenouil T, Meyronet D, von Hoff K, Schüller U, Loiseau H, Figarella-Branger D, Kramm CM, Sturm D, Scheie D, Rauramaa T, Pesola J, Gojo J, Haberler C, Brandner S, Jacques T, Sexton Oates A, Saffery R, Koscielniak E, Baker SJ, Yip S, Snuderl M, Ud Din N, Samuel D, Schramm K, Blattner-Johnson M, Selt F, Ecker J, Milde T, von Deimling A, Korshunov A, Perry A, Pfister SM, Sahm F, Solomon DA, Jones DTW.
Acta Neuropathol. 2023 Jan;145(1):49-69. doi: 10.1007/s00401-022-02516-2. Epub 2022 Nov 27.
Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
Kovalevich J, Santerre M, Langford D.
Methods Mol Biol. 2021;2311:9-23. doi: 10.1007/978-1-0716-1437-2_2.
Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial.
Levy AS, Krailo M, Chi S, Villaluna D, Springer L, Williams-Hughes C, Fouladi M, Gajjar A.
Pediatr Blood Cancer. 2021 Aug;68(8):e29031. doi: 10.1002/pbc.29031. Epub 2021 Apr 12.
Primitive neuroectodermal tumors of the central nervous system.
Rorke LB, Trojanowski JQ, Lee VM, Zimmerman RA, Sutton LN, Biegel JA, Goldwein JW, Packer RJ.
Brain Pathol. 1997 Apr;7(2):765-84. doi: 10.1111/j.1750-3639.1997.tb01063.x.
Central nervous system (CNS) neuroblastoma. A case-based update.
Bianchi F, Tamburrini G, Gessi M, Frassanito P, Massimi L, Caldarelli M.
Childs Nerv Syst. 2018 May;34(5):817-823. doi: 10.1007/s00381-018-3764-3. Epub 2018 Mar 8.
Evaluation and Diagnosis of Central Nervous System Embryonal Tumors (Non-Medulloblastoma).
Cotter JA, Judkins AR.
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):34-45. doi: 10.1177/10935266211018554.
H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
Gessi M, Gielen GH, Hammes J, Dörner E, Mühlen AZ, Waha A, Pietsch T.
J Neurooncol. 2013 Mar;112(1):67-72. doi: 10.1007/s11060-012-1040-z. Epub 2013 Jan 26.
